Manitoba leads the way in breast cancer surgery technology for Canada | Canada News Media
Connect with us

Health

Manitoba leads the way in breast cancer surgery technology for Canada

Published

 on

Manitoba’s health system is rolling out a new, innovative technology that will improve breast cancer care and have a significant impact on patient experience in the days and weeks leading up to surgeries.

The technology, called magnetic seed localization, works as a marker, and is inserted into breast tissue to pinpoint the location of cancerous tumours before surgery. When it’s time for the procedure, the surgeon can use a probe to find the location of the tumor.

“This is a really important advancement for patients in Manitoba. Any time you do breast cancer surgery on a small tumour that you can’t easily feel, you need to have a marker so you know where it is,” explained Dr. Pamela Hebbard, Head of Surgical Oncology at CancerCare Manitoba.

“For the past 50 years, that marker has been a wire placed into the patient’s breast in the hours or days before their surgery. It’s uncomfortable for patients because the end of the wire pokes out and is taped in place. Now, instead of that wire, we will use a little seed that will cause no discomfort.”

Manitoba is the first province across Canada to fully implement the technology across a province.

“Magnetic seed localization will revolutionize how we are managing breast cancer care and breast surgeries in the province,” said Tania D’Amato, Executive Director, Provincial Breast Operations for Shared Health. “The marker, as small as a grain of uncooked rice, can be inserted weeks ahead of surgery at any facility in Manitoba that currently offers wire placement.”

“If that facility is in Winnipeg and the patient’s surgeon and support group are located in a rural community, seed placement can be done at the patient’s convenience weeks ahead of their surgery date,” added D’Amato.

The magnetic seed is roughly the size of a grain of uncooked rice. Photo supplied by Endomag.

Changes are also coming for some breast cancer patients who require appointments for a nuclear medicine injection shortly before surgery to help identify the cancerous tumor, either a day ahead or the morning of the surgery.

“A new non-radioactive detectable liquid, called Magtrace, is also being introduced to breast cancer care. This trace product can be injected while in the operating room before the procedure, eliminating the need for patients to visit nuclear medicine for an injection ahead of surgery,” said D’Amato.

These advancements will offer patients a much more comfortable, streamlined experience and, in many cases, enable care to be available closer to home.

“It is stressful enough to have to prepare for breast surgery, to add on extra, uncomfortable appointments, hours before surgery, just increase that anxiety. The magnetic seed localization technology with the trace product a removes that complexity,” said D’Amato, who said that the addition of using a trace product will also open up 300-400 nuclear medicine appointments per year.

Scheduling for breast cancer surgery will improve with the addition of these new processes, making it easier for last-minute changes to occur and schedules to adapt, if needed.

“For instance, I may have an opening on Monday morning, but we may not be able to use it because we can’t get all the other appointments lined up in time,” said Dr. Hebbard. “Using the same operating room days to inject the MagTrace allows us to be more efficient.”

Magnetic localization procedures will be available at the Breast Health Centre at 400 Taché Ave., Winnipeg, Health Sciences Centre, Boundary Trails Health Centre and the Brandon Regional Health Centre. Trace technology will be available at all sites where breast cancer surgery takes place in the province.

Source link

Continue Reading

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version